Open AccessAnticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
Author(s) -
Vincent J. Nijenhuis,
Jorn Brouwer,
Ronak Delewi,
Renicus S. Hermanides,
Wouter Holvoet,
Christophe Dubois,
Peter Frambach,
Bernard De Bruyne,
Gert K. van Houwelingen,
Jan A.S. Van der Heyden,
Petr Toušek,
Frank van der Kley,
Ian Buysschaert,
Carl E. Schotborgh,
Bert Ferdinande,
Pim van der Harst,
John Roosen,
Joyce Peper,
Frederick W. Thielen,
Leo Veenstra,
Dean R.P.P. Chan Pin Yin,
Martin J. Swaans,
Benno J. Rensing,
Arnoud W.J. van ’t Hof,
Leo Timmers,
Johannes C. Kelder,
Pieter R. Stella,
Jan Baan,
Jurriën M. ten Berg
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1915152
Subject(s) - clopidogrel , medicine , cardiology , myocardial infarction
The roles of anticoagulation alone or with an antiplatelet agent after transcatheter aortic-valve implantation (TAVI) have not been well studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom